
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Yohimbine as a pharmacological probe for alcohol research: a systematic review of rodent and human studies
Dallece E. Curley, Talia R. Vasaturo-Kolodner, Nazzareno Cannella, et al.
Neuropsychopharmacology (2022) Vol. 47, Iss. 12, pp. 2111-2122
Open Access | Times Cited: 9
Dallece E. Curley, Talia R. Vasaturo-Kolodner, Nazzareno Cannella, et al.
Neuropsychopharmacology (2022) Vol. 47, Iss. 12, pp. 2111-2122
Open Access | Times Cited: 9
Showing 9 citing articles:
The Rauvolfia tetraphylla genome suggests multiple distinct biosynthetic routes for yohimbane monoterpene indole alkaloids
Emily Amor Stander, Beata Joanna Lehka, Inês Carqueijeiro, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 23
Emily Amor Stander, Beata Joanna Lehka, Inês Carqueijeiro, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 23
Evaluating the Impact of Concurrent Sucrose Availability on Operant Ethanol Self-Administration in Male and Female Long Evans Rats
Olivia A. Ortelli, Jeffrey L. Weiner
Addiction Neuroscience (2025) Vol. 14, pp. 100196-100196
Open Access | Times Cited: 1
Olivia A. Ortelli, Jeffrey L. Weiner
Addiction Neuroscience (2025) Vol. 14, pp. 100196-100196
Open Access | Times Cited: 1
Mifepristone as a pharmacological intervention for stress‐induced alcohol craving: A human laboratory study
Carolina L. Haass‐Koffler, Molly Magill, Nazzareno Cannella, et al.
Addiction Biology (2023) Vol. 28, Iss. 7
Closed Access | Times Cited: 9
Carolina L. Haass‐Koffler, Molly Magill, Nazzareno Cannella, et al.
Addiction Biology (2023) Vol. 28, Iss. 7
Closed Access | Times Cited: 9
Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacy
Nazzareno Cannella, Veronica Lunerti, Qianwei Shen, et al.
Neuropharmacology (2024) Vol. 257, pp. 110048-110048
Open Access | Times Cited: 2
Nazzareno Cannella, Veronica Lunerti, Qianwei Shen, et al.
Neuropharmacology (2024) Vol. 257, pp. 110048-110048
Open Access | Times Cited: 2
Early social isolation differentially affects the glucocorticoid receptor system and alcohol-seeking behavior in male and female Marchigian Sardinian alcohol-preferring rats
Federica Benvenuti, Sara De Carlo, Laura Rullo, et al.
Neurobiology of Stress (2023) Vol. 28, pp. 100598-100598
Open Access | Times Cited: 2
Federica Benvenuti, Sara De Carlo, Laura Rullo, et al.
Neurobiology of Stress (2023) Vol. 28, pp. 100598-100598
Open Access | Times Cited: 2
Oxytocin reduces noradrenergic-induced opioid-like withdrawal symptoms in individuals on opioid agonist therapy
Brian J. Gully, Zoe E. Brown, Rivkah Hornbacher, et al.
Biological Psychiatry Global Open Science (2024) Vol. 5, Iss. 1, pp. 100395-100395
Open Access
Brian J. Gully, Zoe E. Brown, Rivkah Hornbacher, et al.
Biological Psychiatry Global Open Science (2024) Vol. 5, Iss. 1, pp. 100395-100395
Open Access
The anxiogenic drug yohimbine is a reinforcer in male and female rats
Briana Renda, Francesco Leri
Neuropsychopharmacology (2024) Vol. 50, Iss. 2, pp. 432-443
Closed Access
Briana Renda, Francesco Leri
Neuropsychopharmacology (2024) Vol. 50, Iss. 2, pp. 432-443
Closed Access
Mifepristone as a pharmacological intervention for stress-Induced alcohol craving: a translational crossover randomized trial
Carolina L. Haass‐Koffler, Molly Magill, Nazzareno Cannella, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Carolina L. Haass‐Koffler, Molly Magill, Nazzareno Cannella, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacy
Veronica Lunerti, Qianwei Shen, Hongwu Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Veronica Lunerti, Qianwei Shen, Hongwu Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access